Miguel Lume, coordinator of the Portuguese Retina and Vitreous Group, interviews Ricardo Miguel Japiassú of the Brazilian Society of Ophthalmology. Together, they review the main biomarkers in OCT, their clinical significance, and their impact on risk stratification, progression prediction, and treatment decisions.
The episode provides practical examples of how to incorporate these parameters into daily practice, underscoring the SPO’s commitment to continuing education focused on clinical reality. Episode 5 will be available starting April 2, 2026, on the SPO’s YouTube channel and major audio platforms.